https://www.selleckchem.com/pr....oducts/afuresertib-g
5%) of group 2 (p=0.003). For patients with borderline annulus size in group 1 (n=35, 22.7%) valve size selection was left to the physiciańs choice resulting in selection of the larger prosthesis in 10 (28.6%). In group 2 all patients with borderline annulus (n=36, 39.1%) received the smaller prosthesis (LIM-TAVR). The postprocedural mean transvalvular pressure gradient was significantly higher in the NF-TAVR-group (11.7±4 vs. 10.1±3.6mmHg, p=0.005). LIM-TAVR eliminates the gray zones of sizing and associated PVL, can imp